A detailed history of Schonfeld Strategic Advisors LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 171,090 shares of BCRX stock, worth $1.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
171,090
Previous 452,603 62.2%
Holding current value
$1.3 Million
Previous $2.8 Million 53.52%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.41 - $8.69 $1.8 Million - $2.45 Million
-281,513 Reduced 62.2%
171,090 $1.3 Million
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $1.87 Million - $3.07 Million
452,603 New
452,603 $2.8 Million
Q2 2023

Aug 14, 2023

BUY
$6.96 - $8.81 $843,113 - $1.07 Million
121,137 New
121,137 $852,000
Q4 2022

Feb 14, 2023

SELL
$10.5 - $14.2 $1.96 Million - $2.65 Million
-186,872 Reduced 89.85%
21,100 $242,000
Q3 2022

Nov 14, 2022

BUY
$10.79 - $14.81 $395,734 - $543,171
36,676 Added 21.41%
207,972 $2.62 Million
Q2 2022

Aug 15, 2022

SELL
$7.89 - $17.88 $918,427 - $2.08 Million
-116,404 Reduced 40.46%
171,296 $1.81 Million
Q1 2022

May 16, 2022

BUY
$11.56 - $19.76 $2.71 Million - $4.63 Million
234,500 Added 440.79%
287,700 $4.68 Million
Q4 2021

Feb 14, 2022

BUY
$11.18 - $15.46 $265,424 - $367,035
23,741 Added 80.59%
53,200 $737,000
Q3 2021

Nov 16, 2021

SELL
$14.21 - $17.65 $1.07 Million - $1.33 Million
-75,628 Reduced 71.97%
29,459 $423,000
Q2 2021

Aug 16, 2021

BUY
$9.5 - $17.24 $811,138 - $1.47 Million
85,383 Added 433.33%
105,087 $1.66 Million
Q1 2021

May 17, 2021

SELL
$7.37 - $13.61 $498,853 - $921,220
-67,687 Reduced 77.45%
19,704 $201,000
Q4 2020

Feb 16, 2021

SELL
$3.37 - $8.61 $519,047 - $1.33 Million
-154,020 Reduced 63.8%
87,391 $650,000
Q3 2020

Nov 16, 2020

BUY
$3.43 - $5.53 $254,447 - $410,231
74,183 Added 44.36%
241,411 $1,000
Q2 2020

Aug 14, 2020

BUY
$1.9 - $5.61 $317,733 - $938,149
167,228 New
167,228 $797,000
Q1 2020

May 15, 2020

SELL
$1.6 - $4.11 $635,625 - $1.63 Million
-397,266 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$1.59 - $3.45 $817,314 - $1.77 Million
-514,034 Reduced 56.41%
397,266 $1.37 Million
Q3 2019

Nov 14, 2019

SELL
$2.5 - $3.73 $3.31 Million - $4.93 Million
-1,322,400 Reduced 59.2%
911,300 $2.61 Million
Q2 2019

Aug 14, 2019

BUY
$2.91 - $9.15 $6.5 Million - $20.4 Million
2,233,700 New
2,233,700 $8.47 Million
Q1 2019

May 15, 2019

SELL
$7.38 - $9.72 $81,180 - $106,920
-11,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$6.51 - $9.6 $285,138 - $420,480
-43,800 Reduced 79.93%
11,000 $89,000
Q3 2018

Nov 14, 2018

BUY
$5.52 - $7.99 $302,496 - $437,852
54,800 New
54,800 $418,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.